Exchange: JSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
-4.24% ZAC5 267.00
America/New_York / 3 mai 2024 @ 11:00
FUNDAMENTALS | |
---|---|
MarketCap: | 8 397.97 mill |
EPS: | 5.49 |
P/E: | 9.59 |
Earnings Date: | Feb 21, 2024 |
SharesOutstanding: | 159.45 mill |
Avg Daily Volume: | 0.0824 mill |
RATING 2024-05-03 |
---|
A |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Buy | |
DE: | Neutral | |
P/E: | Neutral | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | n/a | n/a | ||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 9.59 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 9.59 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
ZAC5 293.29 (0.50%) ZAC26.29 |
Date: 2024-05-04 |
Expected Trading Range (DAY) |
---|
ZAC 5 078.99 - 5 455.01 ( +/- 3.57%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | ZAC5 267.00 (-4.24% ) |
Volume | 0.0132 mill |
Avg. Vol. | 0.0824 mill |
% of Avg. Vol | 15.99 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over the counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides pharmaceutical products in a range of therapeutic classes, such as women's health, cannabidiol, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements. In addition, it manufactures and supplies hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection products. The company serves private and public sectors. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.